AMD
ARKG
TEM
Ark’s little AMD diet
Cathie Wood’s Ark Invest spent Thursday doing what active managers do best: making everyone on FinTwit argue. The firm trimmed Advanced Micro Devices again, dumping 8,045 shares worth about $3.3 million from ARKK after already selling $16 million on Tuesday and another $8 million on Wednesday.
AMD has been on a heater — up more than 16% over the last five days — so this looks less like panic and more like Ark taking some chips off the table while the AI trade is still sizzling. If you’ve owned a stock that suddenly starts behaving like it discovered caffeine, you know the temptation.
Meanwhile, Tempus gets the glow-up
While AMD got the chop, Tempus AI got the hug. Ark bought 154,045 shares across ARKG and ARKK, a roughly $7.7 million bet on the AI healthcare name.
Why does that matter? Because Tempus just posted first-quarter revenue up 36.1% to $348.1 million and even raised its full-year outlook. That’s the kind of “we’re not just vibes, we’re growing” story growth investors love.
What investors should read into it
This isn’t a fundamental verdict on AMD. Ark may simply be rebalancing after a big run and rotating into a different AI narrative with more room to run.
- AMD still has the AI and compute tailwind
- Tempus is turning revenue growth into a louder bull case
- Ark is clearly not shy about swapping one hot trade for another
Big picture: Ark’s Wednesday-to-Thursday trade sheet reads like a live portfolio soap opera — trim the chip king, buy the AI upstart, and let the market do the guessing.